US › Healthcare

Radiopharm Theranostics Limited American Depositary Shares (RADX)

US · Healthcare · Biotechnology

$2.92-6.11%
Last close · 2026-08-04

Latest quarter · ended 2025-12-31

Revenue
$1.4M
Net profit
$-26.5M
EPS
$0.00
EPS estimate
$0.00
Net margin
-1,946.2%

Key statistics

Market cap
$24.8M
Forward P/E
0.0
P/B
0.80
Book value
$3.14
EPS (TTM)
$-3.67
52-week high
$10.63
52-week low
$2.73
50-day MA
$4.25
200-day MA
$4.74
Beta
0.80

Analyst view

with an average price target of $17.25.

Shareholding

Institutions
2.29%

Largest institutional holders

FundStake
SILVERARC CAPITAL MANAGEMENT, LLC2.38%
HSBC Holdings PLC0.78%
VGI PARTNERS PTY Ltd0.51%
PNC Financial Services Group Inc0.20%
UBS Group AG0.04%
Rhumbline Advisers0.00%
Stonepine Capital Management Llc0.00%
Strategic Wealth Partners0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Radiopharm Theranostics Limited American Depositary Shares — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.